Nerve agents: what they are, how they work, how to counter them

S Costanzi, JH Machado, M Mitchell - ACS chemical neuroscience, 2018 - ACS Publications
Nerve agents are organophosphorus chemical warfare agents that exert their action through
the irreversible inhibition of acetylcholinesterase, with a consequent overstimulation of …

Reactivators of acetylcholinesterase inhibited by organophosphorus nerve agents

G Mercey, T Verdelet, J Renou… - Accounts of chemical …, 2012 - ACS Publications
Since the September 11, 2001, terrorist attacks in the United States, the specter of a
chemical threat against civilian populations has renewed research interest in chemical …

Butyrylcholinesterase for protection from organophosphorus poisons: catalytic complexities and hysteretic behavior

P Masson, O Lockridge - Archives of biochemistry and biophysics, 2010 - Elsevier
Butyrylcholinesterase is a promiscuous enzyme that displays complex kinetic behavior. It is
toxicologically important because it detoxifies organophosphorus poisons (OP) by making a …

The value of novel oximes for treatment of poisoning by organophosphorus compounds

F Worek, H Thiermann - Pharmacology & therapeutics, 2013 - Elsevier
Poisoning by organophosphorus compounds (OP) still is a major therapeutic problem.
Intentional OP pesticide poisoning results in up to 300.000 deaths each year and highly …

Cholinesterase reactivators and bioscavengers for pre‐and post‐exposure treatments of organophosphorus poisoning

P Masson, F Nachon - Journal of neurochemistry, 2017 - Wiley Online Library
Organophosphorus agents (OP s) irreversibly inhibit acetylcholinesterase (AC hE) causing a
major cholinergic syndrome. The medical counter‐measures of OP poisoning have not …

SAR study to find optimal cholinesterase reactivator against organophosphorous nerve agents and pesticides

L Gorecki, J Korabecny, K Musilek, D Malinak… - Archives of …, 2016 - Springer
Irreversible inhibition of acetylcholinesterase (AChE) by organophosphates leads to many
failures in living organism and ultimately in death. Organophosphorus compounds …

A brief survey on the advanced brain drug administration by nanoscale carriers: with a particular focus on AChE reactivators

S Parvaz, R Taheri-Ledari, MS Esmaeili, M Rabbani… - Life sciences, 2020 - Elsevier
Obviously, delivery of the medications to the brain is more difficult than other tissues due to
the existence of a strong obstacle, which is called blood-brain barrier (BBB). Because of the …

Silibinin inhibits acetylcholinesterase activity and amyloid β peptide aggregation: A dual-target drug for the treatment of Alzheimer's disease

S Duan, X Guan, R Lin, X Liu, Y Yan, R Lin, T Zhang… - Neurobiology of …, 2015 - Elsevier
Alzheimer's disease (AD) is characterized by amyloid β (Aβ) peptide aggregation and
cholinergic neurodegeneration. Therefore, in this paper, we examined silibinin, a flavonoid …

Evolution of and perspectives on therapeutic approaches to nerve agent poisoning

P Masson - Toxicology letters, 2011 - Elsevier
After more than 70 years of considerable efforts, research on medical defense against nerve
agents has come to a standstill. Major progress in medical countermeasures was achieved …

Potent 3‐Hydroxy‐2‐Pyridine Aldoxime Reactivators of Organophosphate‐Inhibited Cholinesterases with Predicted Blood–Brain Barrier Penetration

T Zorbaz, A Braïki, N Maraković… - … A European Journal, 2018 - Wiley Online Library
A new series of 3‐hydroxy‐2‐pyridine aldoxime compounds have been designed,
synthesised and tested in vitro, in silico, and ex vivo as reactivators of human …